• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Spatial and single cell mapping of castleman disease reveals key stromal cell types and cytokine pathways

by MM360 Staff | Jul 1, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Managing IEC-associated enterocolitis following CAR-T therapy in multiple myeloma

by MM360 Staff | Jun 30, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Dual-Antigen Targeting in Myeloma: Improved Responses in Extramedullary Disease

by MM360 Staff | Jun 27, 2025 | Myeloma News

Source: Pharmacy Times articles Shaji Kumar, MD, shares data and insights from the phase 2 RedirecTT-1 study. Read More

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

by MM360 Staff | Jun 26, 2025 | Myeloma News

Source: Pharmacy Times articles Data from a phase 1b study showed significantly reduced toxicity compared with conventional oral dosing. Read More

Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

by MM360 Staff | Jun 25, 2025 | Myeloma News

Source: Myeloma : nature.com subject feeds Post Content Read More

Pharmacists Reimagine Myeloma Care With Insights from ASCO

by MM360 Staff | Jun 25, 2025 | Myeloma News

Source: Pharmacy Times articles Gabe Hinojosa, PharmD, BCOP, shares key data for pharmacists from the 2025 American Society of Clinical Oncology Annual Meeting. Read More
« Older Entries
Next Entries »

Recent Content

  • Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma
  • Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis
  • Patient Perspective: Diagnosis of Multiple Myeloma
  • Treatment of Multiple Myeloma
  • Introduction and Overview of Multiple Myeloma
  • Evaluation and Diagnosis of Multiple Myeloma
  • Label-free protein-structure-sensitive live-cell microscopy for patient-specific assessment of myeloma therapy
  • Spinal intradural lesion as manifestation of multiple myeloma: Illustrative case and systematic review of literature
  • Comparison of MRI, [18F]FDG-PET/CT, and [18F]FDG-PET/MRI for Initial Staging of Multiple Myeloma: A Systematic Review and Meta-analysis
  • Incidence and prevalence of light chain amyloidosis in the United States in 2019–2021 using Optum EHR data
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT